Medication info

Megasimba Tablet 10/10 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
White to light yellow, bilaterally convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Approval withdrawn

MFDS item code 202000774 · Approved 2020.02.10

This product's status changed to Approval withdrawn on 2024.07.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels and adjust the dose at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This drug helps to control cholesterol and triglyceride levels in patients with primary hypercholesterolemia, particularly in cases of heterozygous familial and non-familial hypercholesterolemia, as well as mixed hyperlipidemia. It can also be used as an adjunct to other treatments in patients with homozygous familial hypercholesterolemia. This drug is used in conjunction with dietary therapies, administered when dietary adjustments alone are insufficient. It reduces total cholesterol, LDL cholesterol, Apo B protein, and triglycerides while increasing high-density lipoprotein (HDL) cholesterol, positively impacting vascular health. It is important to check for other causative conditions or medications before initiating drug therapy. This drug is effectively used to reduce the risks of hypercholesterolemia and associated cardiovascular diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. This medicine is administered once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels and adjust the dose at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, 5. General Precautions). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug may cause muscular disorders such as myopathy or rhabdomyolysis. The risk may be higher when taking high doses or in conjunction with certain other medications. Those allergic to any ingredients of this drug or who have active liver disease or persistently elevated liver enzyme levels of unknown origin should not take this medication. Women who are pregnant or breastfeeding should not take this drug, and those planning to become pregnant should consult with a physician. This drug should not be combined with medications that inhibit the CYP3A4 enzyme, such as certain potent antifungals, antibiotics, and antiviral drugs, as it increases the risk of muscle damage. Moreover, it should not be used with medications such as gemfibrozil, cyclosporine, and danazol. While taking this medication, if muscle pain, muscle weakness, or unexplained muscle pain occurs, you should immediately notify your doctor, who may check for muscle damage through blood tests if needed. Patients with liver function disorders should have regular liver function tests before and during the use of this drug, and should discontinue use if liver function worsens. This drug has not been sufficiently studied for safety and efficacy in children and adolescents, especially girls under 10 years old or before menstruation, so caution is needed. Elderly patients may also be sensitive to this medication, so careful administration is necessary, and potential interactions with other drugs should always be considered. During the course of taking this drug, it is advisable to inform the doctor or pharmacist whenever starting a new medication and to limit the intake of certain foods such as grapefruit juice.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headaches
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 86 more
  • abdominal pain
  • nausea
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • rash
  • arthralgia
  • lumbago
  • weakness
  • ocular muscle paralysis
  • cataract
  • taste disturbance
  • extraocular movement disorder
  • facial paresis
  • tremor
  • dizziness
  • sensory abnormalities
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • reduced libido
  • sexual dysfunction
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • increased γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent exposure to air and moisture, preferably at room temperature between 1 degrees and 30 degrees Celsius. This storage method will help maintain the efficacy of the drug for a longer period.

Appearance and packaging

Appearance

White to light yellow, bilaterally convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.